- Report
- April 2021
China
From €2331EUR$2,600USD£2,011GBP
- Report
- April 2021
- 40 Pages
China
From €2331EUR$2,600USD£2,011GBP
- Report
- April 2021
- 50 Pages
China
From €2331EUR$2,600USD£2,011GBP
- Report
- January 2021
- 38 Pages
Global
€1181EUR$1,318USD£1,020GBP
- Report
- May 2020
- 92 Pages
South Africa
From €2241EUR$2,500USD£1,934GBP
- Report
- August 2019
- 30 Pages
China
From €1972EUR$2,200USD£1,702GBP
- Report
- August 2019
- 30 Pages
China
From €1972EUR$2,200USD£1,702GBP
- Report
- August 2018
- 21 Pages
Global
From €8964EUR$10,000USD£7,736GBP
- Report
- July 2018
- 30 Pages
China
From €1972EUR$2,200USD£1,702GBP
- Report
- April 2018
United States
From €7167EUR$7,995USD£6,185GBP
- Training
- 60 Minutes
Global
- Report
- June 2026
Global
From €3577EUR$3,990USD£3,087GBP
From €3577EUR$3,990USD£3,087GBP
- Report
- June 2026
United States
From €3577EUR$3,990USD£3,087GBP
- Report
- June 2026
North America
From €3577EUR$3,990USD£3,087GBP
- Report
- June 2026
Europe
From €3577EUR$3,990USD£3,087GBP
- Report
- June 2026
Middle East
From €3577EUR$3,990USD£3,087GBP
- Report
- June 2026
Asia Pacific
From €3577EUR$3,990USD£3,087GBP
- Report
- June 2026
Europe
From €3577EUR$3,990USD£3,087GBP
- Report
- October 2023
- 146 Pages
Global
From €3720EUR$4,150USD£3,211GBP

The Immune Disorders Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs to treat immune system disorders. These drugs are used to treat a variety of conditions, including allergies, asthma, autoimmune diseases, and cancer. Immune Disorders Drugs are designed to target specific parts of the immune system, such as cytokines, antibodies, and T-cells, to reduce inflammation and improve the body's ability to fight off infection.
The Immune Disorders Drugs market is highly competitive, with many large pharmaceutical companies competing for market share. Some of the major players in the market include AbbVie, AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. These companies are constantly researching and developing new drugs to treat immune system disorders, as well as improving existing treatments. Show Less Read more